Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Emergency department study supports giving dehydrated children fluids by mouth

07.02.2005


Therapy is quicker, less invasive than IV therapy

Oral rehydration therapy, or giving fluids by mouth, is equally effective as giving intravenous fluids to young children dehydrated by common stomach and intestinal inflammations, according to a new study by emergency medicine physicians. Because oral therapy can be started more quickly and is less painful for the child than IV treatment, the researchers say it should be the preferred treatment for children with moderate dehydration.

The research, performed in the emergency department of The Children’s Hospital of Philadelphia, supports previous recommendations by expert groups such as the American Association of Pediatrics and the World Health Organization. The study appears in the February issue of Pediatrics.



Gastroenteritis, an inflammation of the stomach and intestine, causes stomach pain, diarrhea, fever and vomiting in young children, especially during the winter months. The loss of fluids may cause a potentially dangerous dehydration, resulting in some 10 percent of hospitalizations in American children under age five.

Busy hospital emergency departments, such as The Children’s Hospital of Philadelphia, see hundreds of children each year with this condition, frequently caused by infection with rotavirus. "Our study shows that oral rehydration therapy is as effective as intravenous fluid therapy in rehydrating moderately dehydrated children," said Philip Spandorfer, M.D., a pediatric emergency physician at The Children’s Hospital of Philadelphia and primary researcher on the study. "Currently, the majority of pediatric emergency physicians continue to use I.V. therapy for these children, both because they believe parents and referring physicians expect it, and because they believe oral therapy is time-consuming."

There are many benefits to oral rehydration therapy (ORT) that make it more desirable than intravenous fluid therapy (IVF). Patients treated with ORT do not require intravenous access, a potentially painful and difficult procedure in young children. Also, parents who learn to administer ORT correctly have acquired a skill that can be used at home for ongoing and future illnesses.

A randomized controlled clinical trial was performed in the emergency department at Children’s Hospital from December 2001 through April 2003. Seventy-three children between 8 weeks and 3 years were enrolled in the study. Of the 73 patients, 36 were randomized to receive oral rehydration therapy (ORT) and 37 were randomized to receive intravenous fluid therapy (IVF). Less than one third of the group that received ORT required hospitalization, whereas almost half of the IVF group was hospitalized. Patients in the ORT group received small amounts of fluid (Pedialyte) over a period of four hours. After instruction, parents provided the fluid (Pedialyte) to their children.

Half of the participants in both groups were rehydrated successfully in four hours. The time required to start therapy was less in the ORT group, at just under 20 minutes compared to 41 minutes in the IVF group. Physicians also obtained 72-hour post-ED visit information through a follow-up phone call to all participants. Researchers used sham I.V.s so that treating physicians did not know which children were in each group.

"By the end of the study, we realized that most families prefer to start with the oral rehydration therapy for treatment of moderate dehydration," said Dr. Spandorfer. "It is our hope that this study may support greater adoption of ORT by emergency physicians."

Dr. Spandorfer’s co-authors were Evaline Alessandrini, M.D., M.S.C.E.; Mark D. Joffe, M.D.; Russell Localio, M.S.; and Kathy N. Shaw, M.D. All are from the Division of Emergency Medicine at The Children’s Hospital of Philadelphia.

Joey Marie McCool | EurekAlert!
Further information:
http://www.chop.edu

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>